Rogers W J, Oberman A, Kouchoukos N T
Division of Cardiology, Department of Medicine, University of Alabama Medical Center, University Station, Birmingham, Alabama 35294, USA.
Circulation. 1978 Sep;58(3 Pt 2):I50-6.
To identify clinical syndromes benefiting from post-myocardial infarction (MI) left ventricular (LV) aneurysmectomy, 145 consecutively operated patients were followed a mean of 23 +/- 2 months postoperatively. Of the 145 patients, 49% had single-vessel (SV) coronary artery disease (CAD) (> or = 70% stenosis), 49% had multivessel (MV) CAD, and 2% (3 patients) had an unknown extent of CAD. Patients with SV-CAD and MV-CAD had similar distributions of age, sex, aneurysm location, LV end-diastolic pressure, LV ejection fraction, and scar size. In the SV-CAD group, the major operative indication was incapacitating heart failure (CHF), whereas in the MV-CAD group, the major operative indication was angina, often in combination with CHF. Coronary bypass grafting was done in 17/71 (24%) of SV-CAD and 64/71 (90%) of MV-CAD. Acute (30-day) postoperative survival was 89% (129/145) overall, and long-term survival 73%. Throughout the follow-up period, survival was similar in SV-CAD and MV-CAD. At follow-up, 89% of all survivors had CHF symptoms of functional Class II severity or less, and 97% of survivors had angina of Class II severity or less. Improvement in angina was most striking in the multivessel group whose angina had been more severe preoperatively. Thus, in patients undergoing LV aneurysmectomy and concomitant coronary revascularization: 1) SV-CAD is common; 2) SV-CAD has predominantly CHF preoperatively and usually relief of CHF postoperatively; 3) MV-CAD has both angina and CHF preoperatively, with symptomatic relief of both postoperatively; and 4) preoperative CAD extent does not influence survival.
为了确定哪些临床综合征能从心肌梗死(MI)后左心室(LV)室壁瘤切除术获益,对145例连续接受手术的患者进行了术后平均23±2个月的随访。在这145例患者中,49%患有单支血管(SV)冠状动脉疾病(CAD)(狭窄≥70%),49%患有多支血管(MV)CAD,2%(3例患者)CAD病变范围不明。SV - CAD和MV - CAD患者在年龄、性别、室壁瘤位置、左心室舒张末期压力、左心室射血分数和瘢痕大小分布方面相似。在SV - CAD组,主要手术指征是失代偿性心力衰竭(CHF),而在MV - CAD组,主要手术指征是心绞痛,常合并CHF。SV - CAD组17/71(24%)患者和MV - CAD组64/71(90%)患者进行了冠状动脉旁路移植术。术后30天急性生存率总体为89%(129/145),长期生存率为73%。在整个随访期内,SV - CAD和MV - CAD患者的生存率相似。随访时,所有幸存者中89%有功能分级为II级或以下的CHF症状,97%的幸存者有分级为II级或以下的心绞痛。多支血管组术前心绞痛更严重,术后心绞痛改善最为显著。因此,对于接受LV室壁瘤切除术及同期冠状动脉血运重建的患者:1)SV - CAD很常见;2)SV - CAD术前主要是CHF,术后通常CHF缓解;3)MV - CAD术前既有心绞痛又有CHF,术后两者症状均缓解;4)术前CAD范围不影响生存率。